aap Implantate (0N5A) AI Stock Analysis
Top Page
aap Implantate
(LSE:0N5A)
No summary available
aap Implantate (0N5A) vs. iShares MSCI United Kingdom ETF (EWC)
- Market Cap
- EUR 21.34M
- Dividend Yield
- ―
- Average Volume (3M)
- 12
- Price to Earnings (P/E)
- -7.4
- Beta (1Y)
- 0.46
- Revenue Growth
- 1.81%
- EPS Growth
- 42.09%
- Country
- UK
- Employees
- 105
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Specialties
aap Implantate Business Overview & Revenue Model
Company Description
Operating as a medical technology firm, aap Implantate AG specializes in the development, manufacturing, and commercialization of orthopedic trauma devices. The company's market presence spans Germany, the United States, and various international reg...
aap Implantate Peers Comparison
Overall Rating
DE:AFX73Outperform
DE:EUZ69Neutral
DE:GME46Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 73Outperform | EUR 3.13B | 20.95 | 5.52% | 1.57% | -0.06% | -38.81% | |
| 69Neutral | EUR 832.23M | 16.63 | 19.49% | 1.65% | 4.42% | 35.68% | |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| 46Neutral | EUR 11.71M | -15.40 | -4.38% | 4.65% | 1.58% | -148.73% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| GB:0N5A | aap Implantate | 1.46 | -0.02 | -1.35% | |
| DE:AFX | Carl Zeiss Meditec | 34.98 | -7.07 | -16.82% | |
| DE:EUZ | Eckert & Ziegler Strahlen und Medizintechnik | 13.30 | -3.09 | -18.88% | |
| DE:GME | Geratherm Medical | 2.15 | -1.52 | -41.40% | |
| DE:MF6 | MagForce AG | ― | ― | ― | |
| DE:E8X | elexxion AG | 0.01 | -0.13 | -90.71% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.